XARELTO 15 MG RIVAROXABAN TABLETS

Xarelto 15 mg Rivaroxaban Tablets provide reliable, mid-strength anticoagulation support for individuals who require prevention of blood clots under the guidance of their healthcare professional. Rivaroxaban is a direct oral anticoagulant (DOAC) that selectively inhibits Factor Xa, a key enzyme in the clotting cascade. By reducing clot formation, it helps maintain smooth blood flow and lowers the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related complications.

The 15 mg strength is commonly prescribed during the initial or intensified phase of treatment for clot prevention, such as in the first weeks following a thromboembolic event. It provides predictable and targeted anticoagulation, supporting effective management of clotting risks while allowing easier integration into daily routines without frequent monitoring.

Manufactured under strict pharmaceutical-grade standards, Xarelto 15 mg Rivaroxaban Tablets ensure consistent potency, purity, and safety. Their easy-to-swallow formulation supports daily adherence, making them a trusted choice for managing blood clot risk under medical supervision.

Key Benefits

Supports Blood Clot Prevention:
Helps reduce the risk of DVT, PE, and other clot-related complications under professional guidance.

Promotes Healthy Circulation:
Inhibits Factor Xa to maintain smoother, safer blood flow and prevent clot formation.

Provides Targeted Anticoagulation:
Ideal for initial or intensified therapy phases, offering effective clot prevention when it’s most needed.

Key Features

Mid-Strength 15 mg Dose:
Prescribed for initial treatment or intensified anticoagulation phases as directed by a healthcare provider.

Pharmaceutical-Grade Quality:
Manufactured with strict quality controls to ensure consistent potency, purity, and safety.

Convenient Tablet Formulation:
Easy-to-swallow tablets designed for predictable absorption and daily use.